LeMaitre Vascular Profit Margin 2010-2025 | LMAT

Current and historical gross margin, operating margin and net profit margin for LeMaitre Vascular (LMAT) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. LeMaitre Vascular net profit margin as of March 31, 2025 is 19.96%.
LeMaitre Vascular Annual Profit Margins
LeMaitre Vascular Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $1.878B $0.220B
LeMaitre Vascular, Inc. is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects the people worldwide. LeMaitre develops, manufactures, and markets disposable and implantable vascular devices to address the needs of vascular surgeons and interventionalists. LeMaitre's diversified product portfolio consists of twelve well-known brand name products used in arteries and veins outside of the heart and are supported by a growing, specialized and highly trained organization of vascular sales professionals. LeMaitre Vascular offers a wide range of innovative products to vascular surgeons and interventionalists for improving procedure efficacy and minimizing patient recovery time.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $235.365B 28.30
Boston Scientific (BSX) United States $147.057B 36.81
Stryker (SYK) United States $145.454B 30.41
EssilorLuxottica (ESLOY) France $130.907B 0.00
Medtronic (MDT) Ireland $112.941B 16.01
Lonza Group Ag (LZAGY) Switzerland $50.659B 0.00
Haleon (HLN) United Kingdom $49.106B 27.97
ResMed (RMD) United States $36.856B 27.68
Agilent Technologies (A) United States $34.008B 22.17
GE HealthCare Technologies (GEHC) United States $33.609B 15.96
Terumo (TRUMY) Japan $26.946B 35.00
Koninklijke Philips (PHG) Netherlands $22.201B 15.96
Insulet (PODD) United States $21.270B 83.49
Zimmer Biomet Holdings (ZBH) United States $18.645B 11.98
Baxter (BAX) United States $16.114B 12.03
Smith & Nephew SNATS (SNN) United Kingdom $13.196B 0.00
Sunny Optical Technology (SNPTF) China $9.076B 0.00
Demant (WILYY) Denmark $8.854B 0.00
Bio-Rad Laboratories (BIO) United States $6.264B 21.80
Lantheus Holdings (LNTH) United States $5.587B 14.09
Prestige Consumer Healthcare (PBH) United States $4.206B 18.79
Perrigo (PRGO) Ireland $3.763B 9.54
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Haemonetics (HAE) United States $3.435B 15.65
ICU Medical (ICUI) United States $3.309B 24.40
Envista Holdings (NVST) United States $3.259B 27.08
GN Store Nord (GNNDY) Denmark $2.362B 19.57
QuidelOrtho (QDEL) United States $2.094B 14.40
AtriCure (ATRC) United States $1.635B 0.00
Acuren (TIC) United States $1.305B 0.00
Neogen (NEOG) United States $1.238B 15.85
AdaptHealth (AHCO) United States $1.181B 11.99
BioLife Solutions (BLFS) United States $1.128B 0.00
Green Thumb Industries (GTBIF) United States $1.075B 24.19
Kestra Medical Technologies (KMTS) United States $1.001B 0.00
Phibro Animal Health (PAHC) United States $0.989B 12.64
InMode (INMD) Israel $0.903B 9.10
Evolus (EOLS) United States $0.660B 0.00
CeriBell (CBLL) United States $0.642B 0.00
Owens & Minor (OMI) United States $0.606B 5.03
Capricor Therapeutics (CAPR) United States $0.600B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.581B 0.00
Curaleaf Holdings (CURLF) Canada $0.554B 0.00
Valneva SE (VALN) France $0.534B 0.00
Tilray Brands (TLRY) Canada $0.429B 0.00
Surmodics (SRDX) United States $0.415B 0.00
VAREX IMAGING (VREX) United States $0.359B 13.21
SNDL (SNDL) Canada $0.349B 0.00
Aurora Cannabis (ACB) Canada $0.340B 60.40
Canopy Growth (CGC) Canada $0.289B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.283B 0.00
Cerus (CERS) United States $0.271B 0.00
Sanuwave Health (SNWV) United States $0.268B 0.00
Viemed Healthcare (VMD) United States $0.267B 22.50
ZimVie (ZIMV) United States $0.265B 12.06
Cresco Labs (CRLBF) United States $0.261B 0.00
Quanterix (QTRX) United States $0.259B 0.00
Sanara MedTech (SMTI) United States $0.257B 0.00
Brainsway (BWAY) Israel $0.222B 58.65
Biote (BTMD) United States $0.220B 6.18
OraSure Technologies (OSUR) United States $0.218B 0.00
Omeros (OMER) United States $0.212B 0.00
TriSalus Life Sciences (TLSI) United States $0.199B 0.00
Organigram Global (OGI) Canada $0.197B 0.00
High Tide (HITI) Canada $0.190B 0.00
Utah Medical Products (UTMD) United States $0.185B 15.09
Verano Holdings (VRNOF) United States $0.183B 0.00
Exagen (XGN) United States $0.155B 0.00
Vireo Growth (VREOF) United States $0.141B 0.00
FitLife Brands (FTLF) United States $0.130B 16.05
Jin Medical (ZJYL) China $0.108B 0.00
MacroGenics (MGNX) United States $0.108B 0.00
Veru (VERU) United States $0.099B 0.00
Quipt Home Medical (QIPT) United States $0.092B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.091B 0.00
Fonar (FONR) United States $0.090B 11.61
TerrAscend (TSNDF) Canada $0.078B 0.00
Agape ATP (ATPC) $0.078B 0.00
InterCure (INCR) Israel $0.071B 0.00
Cytosorbents (CTSO) United States $0.068B 0.00
Apyx Medical (APYX) United States $0.067B 0.00
Zynex (ZYXI) United States $0.062B 0.00
Jushi Holdings (JUSHF) United States $0.057B 0.00
ImmuCell (ICCC) United States $0.057B 0.00
Modular Medical (MODD) United States $0.047B 0.00
Nephros (NEPH) United States $0.040B 54.21
United-Guardian (UG) United States $0.038B 13.18
Rockwell Medical (RMTI) United States $0.034B 0.00
Allurion Technologies (ALUR) United States $0.020B 0.00
Cellectar Biosciences (CLRB) United States $0.020B 0.00
Safety Shot (SHOT) United States $0.019B 0.00
Flora Growth (FLGC) United States $0.018B 0.00
INLIF (INLF) $0.014B 0.00
Trinity Biotech (TRIB) Ireland $0.013B 0.00
Meihua Medical Technologies (MHUA) China $0.012B 0.00
Innovative Eyewear (LUCY) United States $0.009B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
Senestech (SNES) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.005B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00